Welcome to our dedicated page for Agilent Technologies SEC filings (Ticker: A), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Agilent Technologies Inc. (NYSE: A) SEC filings page provides access to the company’s official regulatory disclosures filed with the U.S. Securities and Exchange Commission. These documents include current reports on Form 8-K, annual and quarterly reports when available, and other filings that describe Agilent’s financial condition, governance changes, and capital markets activities.
Agilent uses Form 8-K to report material events such as quarterly financial results and executive leadership changes. For example, the company has filed 8-Ks to furnish earnings press releases for fiscal quarters, explaining revenue, net income, segment performance for the Life Sciences and Diagnostics Markets Group, Agilent CrossLab Group, and Applied Markets Group, and to discuss the use of non-GAAP financial measures. Separate 8-K filings describe the resignation of a chief financial officer, the appointment of an interim CFO, and the subsequent appointment of a new senior vice president and chief financial officer, including related compensation and equity awards.
Through its filings, Agilent explains why it presents non-GAAP financial information, stating that these measures are intended to provide meaningful supplemental insight into operational performance and to facilitate comparisons with historical results and other companies. The company notes that non-GAAP figures exclude items such as restructuring and amortization, are monitored alongside GAAP results, and may differ from similar measures used by other issuers.
On Stock Titan, these SEC filings are updated from EDGAR and can be paired with AI-powered summaries that highlight key points, such as changes in leadership, segment trends, and the rationale behind non-GAAP adjustments. Users can quickly locate current reports, review disclosures about executive appointments and compensation arrangements, and understand how Agilent communicates its financial performance and governance decisions to regulators and investors.
Agilent Technologies director Koh Boon Hwee received an award of 2,158 shares of common stock valued at $111.75 per share as compensation for non-employee directors, fully vested upon grant. In connection with this award and vesting of restricted stock units, he surrendered 648 shares to Agilent to cover tax liabilities.
Footnotes note an additional 106.132 shares acquired through the dividend reinvestment plan, which he has elected to defer. After these transactions, Koh directly holds 63,184.351 shares of Agilent common stock.
Agilent Technologies director Mikael Dolsten received a stock award, increasing his holdings. He was granted 2,158 shares of Agilent common stock at a value of $111.75 per share as a fully vested award for non-employee directors. Following the grant, he directly holds 7,138.2100 shares of common stock. Dolsten elected to defer receipt of 1,079 of the granted shares, and an additional 7.182 shares were acquired and deferred through the company’s dividend reinvestment plan.
Agilent Technologies director Judy L. Brown received a stock award of 2,158 shares of common stock on March 19, 2026. The award for non-employee directors is fully vested upon grant and was valued at $111.75 per share. Following this grant, Brown directly owns 3,835 Agilent shares. This is a compensation-related share acquisition rather than an open-market purchase.
Agilent Technologies director receives stock award
Agilent Technologies director Mala Anand acquired 2,158 shares of common stock on an award valued at $111.75 per share. The footnote explains this was a fully vested stock grant for non-employee directors, meaning it is compensation, not an open-market purchase. After the award, Anand directly holds 16,705 Agilent shares.
Agilent Technologies, Inc. reported results of its annual stockholder meeting and governance changes. Stockholders approved a Fourth Amended and Restated Certificate of Incorporation that will declassify the board of directors over a three-year period. The board simultaneously adopted Fourth Amended and Restated Bylaws to align with this phased declassification, including allowing stockholders to remove directors with or without cause beginning with the 2029 annual meeting, when the board will no longer be classified.
At the meeting, about 250.3 million shares of common stock, representing approximately 88% of shares outstanding, were represented. Stockholders elected four directors to three-year terms, approved on a non-binding basis the compensation of named executive officers, and ratified PricewaterhouseCoopers LLP as independent auditor for the 2026 fiscal year. They also approved the charter amendment to declassify the board.
Agilent Technologies, Inc. reported that Rodney Gonsalves, its Vice President, Corporate Controller and Principal Accounting Officer, plans to retire in January 2027, with the exact date to be set later. The company states that his departure is not related to any disagreement regarding accounting practices, financial statements, internal controls, or operations.
By giving advance notice, Agilent plans to conduct a comprehensive search for his successor and have Mr. Gonsalves help with an orderly transition of his duties to the new principal accounting officer.
Agilent Technologies reported net revenue of $1,798 million for the quarter ended January 31, 2026, up 7% from $1,681 million a year earlier, with growth across all three segments and all regions. Life Sciences and Diagnostics Markets revenue rose 5%, Agilent CrossLab 9%, and Applied Markets 7%, helped by a favorable foreign currency impact of up to 3% on segment growth.
Net income was $305 million, down slightly from $318 million, and diluted EPS was $1.07 versus $1.11. Operating income was $353 million, after $89 million of unallocated costs including amortization, restructuring, and transformation expenses. Cash from operations declined to $268 million from $431 million, reflecting working capital swings and compensation payments, but cash and cash equivalents remained strong at $1,758 million.
The company continued returning capital, paying a quarterly dividend of $0.255 per share (about $72 million) and repurchasing 1.05 million shares for $152 million under its 2024 buyback program. Management notes tariff-related cost pressure but expects to offset this during fiscal 2026 through supply chain changes, pricing, and efficiency initiatives.
Agilent Technologies Senior Vice President Angelica Riemann reported a small tax-related share disposition. On the vesting of restricted stock units, she surrendered 89 shares of common stock at $121.38 per share back to Agilent to cover tax liabilities under Rule 16b-3, rather than selling shares in the open market. After this transaction, she directly holds 26,535.1416 shares of Agilent common stock, and an additional 2,610.6966 shares are held indirectly through her spouse. Footnotes note modest additional shares previously acquired through Agilent’s dividend reinvestment plan.
AGILENT TECHNOLOGIES, INC. President and CEO Padraig McDonnell reported a tax-related stock transaction. On the vesting of restricted stock units, he surrendered 279 shares of common stock to Agilent at $121.38 per share to cover withholding taxes. Following this Rule 16b-3 tax-withholding disposition, he directly holds 66,260 shares of Agilent common stock.
Agilent Technologies Senior Vice President Jonah Prevost Kirkwood reported a small share disposition related to taxes, not an open-market sale. He surrendered 124 shares of common stock to Agilent Technologies, Inc. at a price of $121.38 per share to cover tax liabilities on vesting restricted stock units, leaving him with 14,138 shares held directly.